Stock AFXA CARL ZEISS MEDITEC AG
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Carl Zeiss Meditec AG Deutsche Boerse AG

Equities

AFXA

US14218T1051

Delayed Deutsche Boerse AG
Other stock markets
 08:33:01 2024-06-17 EDT 		5-day change 1st Jan Change
71 EUR -13.41% Intraday chart for Carl Zeiss Meditec AG -14.46% -25.65%
03:52pm CARL ZEISS MEDITEC AG : Receives a Buy rating from DZ Bank ZD
02:06pm Goldman rates Carl Zeiss Meditec at 'Sell' - Target 90 euros DP

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses

  • The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
  • With an expected P/E ratio at 29.59 and 23.87 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • With an enterprise value anticipated at 3.56 times the sales for the current fiscal year, the company turns out to be overvalued.
  • The company appears highly valued given the size of its balance sheet.
  • The company is highly valued given the cash flows generated by its activity.
  • The company is not the most generous with respect to shareholders' compensation.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
CARL ZEISS MEDITEC AG Stock Carl Zeiss Meditec AG
-25.65% 8.07B -
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+6.66% 218B
B
DANAHER CORPORATION Stock Danaher Corporation
+10.00% 189B
B-
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+27.67% 151B
B-
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+31.97% 113B
A-
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
-0.15% 64.02B
A-
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.95% 52.6B
B+
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+1.85% 49.85B
B+
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-5.52% 37.89B
A
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+0.62% 34.92B -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. AFX Stock
  4. AFXA Stock
  5. Ratings Carl Zeiss Meditec AG